Aptamer Group Secures $2.2m Series A Investment

Arron Tolley, CEO – I’m delighted to announce that Aptamer Group Ltd, has recently closed its Series A investment round; attracting international interest and securing $2.2m of funding from overseas investors, to support its pioneering aptamer development pipeline.

Aptamer technology is rapidly evolving and will continue to have a significant impact on the life sciences market […]

Congratulations to Dr Mateja Vidic

1st June 2018

We are very pleased to announce that Mateja Vidic has completed and been awarded her PhD for the Development of DNA Aptamers Specific for Non-Small Cell Lung Cancer by the University of Ljubljana, Slovenija. Her experience in aptamer selection and application is a valuable asset to our lab and we are very proud […]

Spotlight: Laboratory Technician, Katriona Harrison

Working at Aptamer Group:
The continued success of Aptamer Group means that the scientific team continues to grow. One member who joined us this summer is Katriona.  Now she has had the chance to establish herself, we took the opportunity to catch up with her.

Hi Katriona, please tell us a little about yourself.

I am currently a […]

Spotlight: Selection Technician, Mateja Vidic

19th September, 2017
An insight into working at Aptamer Group
Mateja joined Aptamer Group in August as a Selection Technician. Now she has had the chance to  settle in and become established in her role, we took the opportunity to catch up with her.
Can you tell us a bit about your Ph.D.?
I have just finished the research […]

  • Sales and Marketing Executive

Spotlight: Sales and Marketing Executive, Joel Sutcliffe

6th June 2017
An insight into working at Aptamer Group

Joel joined the Aptamer Group in April as Sales and Marketing Executive; now he’s established in the role we thought it would be a great time to catch up with him and see how he is getting on.

Hi Joel, firstly, what did you do before joining the company?

I […]